Download presentation
1
EMBOLOTHERAPY IN EPISTAXIS
Sasa Ristic Center of Radiology, Clinical center Nis, Serbia
2
INTRODUCTION Bleeding from nostril, nasal cavity or nasopharynx
common medical problem, with approximately 60% of the adult population having experienced at least 1 episode during their lives fortunately, most cases resolve spontaneously only 6% of epistaxis cases require medical attention Most often self limited, but can often be serious and life threatening
3
INTRODUCTION equally frequent in males and females
The prevalence is increased for children less than 10 years of age and then rises again after the age of 40 years (increase of vascular disease, hypertension, iatrogenic and pathologic bleeding, and trauma)
4
ETIOLOGY Local factors Systemic factors Combination of both
5
ETIOLOGY LOCAL FACTORS: Anatomic defect of the nasal septum Trauma
Surgical complication Vascular malformation Inflammatory Neoplasm
6
ETIOLOGY SYSTEMIC FACTORS: Hypertension
Antiinflammatory analgesic medication (NSAID) Cardiac, pulmonary, GI and renal disorders Hereditary hemorrhagic telangiectasia Hemostatic disorders
7
BLOOD SUPPLY OF THE NASAL CAVITY
Branches of internal carotid system : Anterior ethmoidal artery Posterior ethmoidal artery Branches of external carotid system : Sphenopalatine artery - major branch Greater palatine artery Superior labial branch of facial artery Infraorbital branch of maxillary artery
8
KIESSELBACH’S PLEXUS (Little’s area)
Most common site for anterior epistaxis In anterior inferior part of nasal septum Mainly anterior epistaxis septal br. of sphenopalatine anterior ethmoidal septal br. of superior labial greater palatine arteries anastomose here readily accessible area hemorrhage from this region can usually be managed conservatively
9
WOODRUFF’S PLEXUS Most common site for posterior epistaxis
Posterior end of middle turbinate Sphenopalatine artery anastomoses with posterior pharyngeal artery
10
CLASSIFICATION Anterior epistaxis Posterior epistaxis More common
Occurs in children and young adults Usually due to nasal mucosal dryness Alarming as bleeding seen readily but generally less severe Posterior epistaxis Usually older population HTN and ASVD are the most common causes Significant bleeding in posterior pharynx More severe and treatment more challenging
11
EPISTAXIS TREATMENT OPTIONS
Conservative therapy applying pressure to the nostrils, chemical cautery or electrocautery, vasoconstricting agents, cryotherapy, anterior and posterior packs (AP packs) Surgical ligation (IMA, SPA, ECA, ethmoid arteries) Endovascular embolization of the arteries supplying the posterior nasal fossa
12
ENDOVASCULAR TREATMENT
Endovascular treatment of epistaxis was first presented as an alternative to surgery by Sokoloff et al (1) in 1974. consisted of particle embolization of the ipsilateral IMA Lasjaunias et al (2) stressed the importance of obtaining a diagnostic preembolization angiogram of the ICA and ECA 1. Sokoloff J, Wickbom I, McDonald D, et al. Therapeutic percutaneous embolization in intractable epistaxis. Radiology 1974;111:285–87 2. Lasjaunias P, Marsot-Dupuch K, Doyon D. The radio-anatomical basis of arterial embolisation for epistaxis. J Neuroradiol 1979;6:45–53
13
THE IMPORTANCE OF A DG ANGIOGRAM
contrast extravasation, tumor blush, vascular malformation, traumatic pseudoaneurysm, vascular anomalies and variants, “dangerous” anastomoses between the ECA and ICA or OphA (may open in case of increased pressure during embolization)
14
POTENTIAL CONNECTION BETWEEN ICA AND ECA
Artery of the foramen rotundum Vidian artery Middle meningeal artery Accesory meningeal artery Ascending pharingeal artery Inferolateral trunk Meningohypophiseal trunk Communications between the facial artery, sphenopalatine artery and the ophtalmic artery Filing of ECA-ICA anastomoses - risk of cerebral embolization !
15
EMBOLIZATION AGENTS pledgets of gelatin sponge (Gelfoam),
Gelfoam powder, polyvinyl alcohol (PVA), particles, platinum coils, or a combination of materials 100 – 300 300 – 500 500 – 700 700 – 900 900 – 1200
16
EMBOLIZATION TECHNIQUE
Local anaesthesia Transfemoral aproach Bilateral angiography of the ICA and ECA to rule out vascular variants (e.g. distal anastomosis between the ICA and ECA) or specific pathologies
17
EMBOLIZATION TECHNIQUE
Local anaesthesia Transfemoral aproach Bilateral angiography of the ICA and ECA to rule out vascular variants (e.g. distal anastomosis between the ICA and ECA) or specific pathologies
18
EMBOLIZATION TECHNIQUE
Selective cateterization of ECA branches – internal maxillary artery and sphenopalatine artery distal to any branches that did not supply the nasal mucosa. Carefully monitoring under fluoroscopy and with repeated angiograms
19
EMBOLIZATION TECHNIQUE
Selective cateterization of ECA branches – internal maxillary artery and sphenopalatine artery distal to any branches that did not supply the nasal mucosa. Carefully monitoring under fluoroscopy and with repeated angiograms
20
EMBOLIZATION TECHNIQUE
Slow and carefull injection of embolic material to avoid reflux in anastomosis of the ICA Terminate when the flow in the capillary bed and distal branches of the embolized artery is significantly reduced or stopped
21
IDIOPATHIC POSTERIOR EPISTAXIS
Generally, at least 70% of cases are idiopathic In most of these cases, findings of angiography will be normal ! Because embolization through the ICA and OphA cannot be considered safe, the single most important vessel to embolize is the ipsilateral IMA and its branches
22
NASOPHARINGEAL CARCINOMA
23
NASOPHARINGEAL CARCINOMA
24
OSLER-WEBER-RENDU DISEASE
25
OSLER-WEBER-RENDU DISEASE
26
OSLER-WEBER-RENDU DISEASE
27
OSLER-WEBER-RENDU DISEASE
28
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA
29
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA
30
COMPLICATIONS OF EMBOLIZATION
minor transient, major transient, or persistent
31
COMPLICATIONS OF EMBOLIZATION
MINOR TRANSIENT (25%–59%): Headache facial pain, trismus facial edema facial numbness facial cold hypersensitivity, paresthesias mild palate ulceration groin hematoma, groin pain fever
32
COMPLICATIONS OF EMBOLIZATION
MAJOR TRANSIENT (0%–1%): skin slough temporary hemiparesis temporary monocular visual field loss mucosal necrosis
33
COMPLICATIONS OF EMBOLIZATION
PERSISTENT (up to 2%): facial scarring following ischemia monocular blindness peripheral facial nerve paralysis cerebral infarction ischemic sialadenitis requiring surgery NECROSIS OF ALA
34
CONCLUSION Transarterial embolization is an accepted treatment option for intractable epistaxis, when epistaxis is refractory to conservative management It is associated with a small risk of serious complications be aware of possible “dangerous” anastomoses and perform diagnostic angiography before treatment selective obliteration of the most distal blood vessels can easily be repeated if necessary
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.